MedPath

Gel of tea tree oil nanoemulsion in treatment of acne

Phase 3
Conditions
acne vulgaris.
Acne vulgaris
L70.0
Registration Number
IRCT20150902023864N4
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
174
Inclusion Criteria

No use of any medicine (including body building agents) in the last 14 days
Age: 15-30 years

Exclusion Criteria

Pregnancy
Lactation
Hormone diseases
Acute physical disability

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Inflammatory and noninflammatory lesions. Timepoint: First day- 6th week. Method of measurement: counting lesions using manual lens.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: first day and 6th week. Method of measurement: questionnaire (any possible side ffects).
© Copyright 2025. All Rights Reserved by MedPath